您的位置: 首页 > 农业专利 > 详情页

CELLULES APOPTOTIQUES THÉRAPEUTIQUES DESTINÉES À LA THÉRAPIE DU CANCER
专利权人:
Enlivex Therapeutics Ltd.
发明人:
NOVIK, Shai,MEVORACH, Dror
申请号:
EP18812666
公开号:
EP3612192A4
申请日:
2018.06.07
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
Methods of use of early apoptotic cell populations and compositions thereof disclosed herein, including methods of treating a cancer or a tumor, extending survival times of a subject suffering from a cancer or a tumor, and reducing the size or reducing the growth rate of a cancer or a tumor, wherein subjects are administered apoptotic cells or compositions thereof. Cancers may include solid tumors or diffuse cancers, for example leukemia. In certain instances compositions may include additional chemotherapeutic agent. Further, inactivated early apoptotic cell populations are disclosed and methods of making the same.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充